Apertura Gene Therapy pioneers genetic medicines for challenging diseases by innovatively engineering AAV capsids, regulatory elements, and payloads. Their approach overcomes current gene therapy limitations, offering hope for patients with few treatment options.

Oceanium creates natural food, nutraceuticals, and sustainable materials from seaweed sourced sustainably.

Inspired by a national transportation strike in Argentina, the startup integrates software and hardware to address urban challenges. Since its incorporation in Delaware in 2014, it has expanded its presence with offices in China, New York, and Argentina, driving innovative solutions for urban mobility.

Lirum Therapeutics is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of debilitating diseases. By acquiring, developing, and commercializing innovative drug candidates with unique mechanisms of action, Lirum aims to create impactful therapeutic solutions that leverage promising regulatory pathways and commercial opportunities.

Stitch is a Professional Employer Organization (PEO) established in 2023, dedicated to enhancing independent medical practices across the nation. Based in New York City, Stitch boosts employee satisfaction by providing tailored benefits, ensuring that healthcare professionals can focus on what they do best—caring for their patients.

Mesenbio, a preclinical biopharmaceutical company based at the University of York, leverages its innovative Cell Line Extracellular Vesicle Release (CLEVR) technique to enhance extracellular vesicle therapy. This groundbreaking approach addresses common challenges in the field, paving the way for a more diverse and effective treatment pipeline.

Synch offers a comprehensive Global Trade Management (GTM) system that seamlessly integrates a company's revenue streams, enhancing efficiency and promoting growth. By unifying trade processes, Synch empowers businesses to optimize their operations and navigate the complexities of global commerce with ease.

Prasinotech is a dynamic biotech company specializing in trading. They offer innovative solutions in the field, blending cutting-edge technology with sustainable practices. Join Prasinotech in revolutionizing the biotech industry.

GlycoMar creates innovative healthcare and personal care products. Their biotechnology solutions cater to the human market, providing cutting-edge solutions for various health and wellness needs.

Moonlight, incorporated in 2019 and officially launched in August 2021, quickly gained traction with over 4,500 sign-ups within a week of advertising, demonstrating its appeal and potential in the market.

Gabriela Hearst offers a diverse range of stylish clothing and accessories for both women and men, including jackets, dresses, knitwear, footwear, handbags, and jewelry. Their collection features everything from boots and sandals to belts and hats, ensuring a chic and sophisticated look for every occasion.

Apertura Gene Therapy pioneers genetic medicines for challenging diseases by innovatively engineering AAV capsids, regulatory elements, and payloads. Their approach overcomes current gene therapy limitations, offering hope for patients with few treatment options.

Lirum Therapeutics is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of debilitating diseases. By acquiring, developing, and commercializing innovative drug candidates with unique mechanisms of action, Lirum aims to create impactful therapeutic solutions that leverage promising regulatory pathways and commercial opportunities.

Mesenbio, a preclinical biopharmaceutical company based at the University of York, leverages its innovative Cell Line Extracellular Vesicle Release (CLEVR) technique to enhance extracellular vesicle therapy. This groundbreaking approach addresses common challenges in the field, paving the way for a more diverse and effective treatment pipeline.

Inspired by a national transportation strike in Argentina, the startup integrates software and hardware to address urban challenges. Since its incorporation in Delaware in 2014, it has expanded its presence with offices in China, New York, and Argentina, driving innovative solutions for urban mobility.

Stitch is a Professional Employer Organization (PEO) established in 2023, dedicated to enhancing independent medical practices across the nation. Based in New York City, Stitch boosts employee satisfaction by providing tailored benefits, ensuring that healthcare professionals can focus on what they do best—caring for their patients.

Moonlight, incorporated in 2019 and officially launched in August 2021, quickly gained traction with over 4,500 sign-ups within a week of advertising, demonstrating its appeal and potential in the market.

Oceanium creates natural food, nutraceuticals, and sustainable materials from seaweed sourced sustainably.

Apertura Gene Therapy pioneers genetic medicines for challenging diseases by innovatively engineering AAV capsids, regulatory elements, and payloads. Their approach overcomes current gene therapy limitations, offering hope for patients with few treatment options.

Oceanium creates natural food, nutraceuticals, and sustainable materials from seaweed sourced sustainably.

Stitch is a Professional Employer Organization (PEO) established in 2023, dedicated to enhancing independent medical practices across the nation. Based in New York City, Stitch boosts employee satisfaction by providing tailored benefits, ensuring that healthcare professionals can focus on what they do best—caring for their patients.

Apertura Gene Therapy pioneers genetic medicines for challenging diseases by innovatively engineering AAV capsids, regulatory elements, and payloads. Their approach overcomes current gene therapy limitations, offering hope for patients with few treatment options.

Oceanium creates natural food, nutraceuticals, and sustainable materials from seaweed sourced sustainably.

Inspired by a national transportation strike in Argentina, the startup integrates software and hardware to address urban challenges. Since its incorporation in Delaware in 2014, it has expanded its presence with offices in China, New York, and Argentina, driving innovative solutions for urban mobility.

Lirum Therapeutics is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of debilitating diseases. By acquiring, developing, and commercializing innovative drug candidates with unique mechanisms of action, Lirum aims to create impactful therapeutic solutions that leverage promising regulatory pathways and commercial opportunities.

Gabriela Hearst offers a diverse range of stylish clothing and accessories for both women and men, including jackets, dresses, knitwear, footwear, handbags, and jewelry. Their collection features everything from boots and sandals to belts and hats, ensuring a chic and sophisticated look for every occasion.

Mesenbio, a preclinical biopharmaceutical company based at the University of York, leverages its innovative Cell Line Extracellular Vesicle Release (CLEVR) technique to enhance extracellular vesicle therapy. This groundbreaking approach addresses common challenges in the field, paving the way for a more diverse and effective treatment pipeline.

Inspired by a national transportation strike in Argentina, the startup integrates software and hardware to address urban challenges. Since its incorporation in Delaware in 2014, it has expanded its presence with offices in China, New York, and Argentina, driving innovative solutions for urban mobility.